TrialProceedings of the National Academy of Sciences of the United States of America2023

MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial.

Eduardo Caverzasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.